Mail

Australia markets closed

ALL ORDS
7,270.00
+3.40(+0.05%)
ASX 200
7,068.80
+3.60(+0.05%)
AUD/USD
0.6453
+0.0036(+0.56%)
OIL
89.47
-0.16(-0.18%)
GOLD
1,947.50
+7.90(+0.41%)
Bitcoin AUD
41,282.69
+95.72(+0.23%)

FEELING THE PINCH?

Beat the cost-of-living squeeze with our pro tips and helpful hacks - sign up now

Entheon Biomedical Corp. (ENTBF)

Other OTC - Other OTC Delayed price. Currency in USD

Add to watchlist

0.0176

0.0000

(0.00%)

As of 03:08PM EDT. Market open.

Currency in USD

Valuation measures⁴

Market cap (intra-day)	876.83k
Enterprise value	515.55k
Trailing P/E	1.33
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	3.18
Price/book (mrq)	2.88
Enterprise value/revenue	1.17
Enterprise value/EBITDA	-0.50

Trading information

Stock price history

Beta (5Y monthly)	0.89
52-week change ³	-48.57%
S&P500 52-week change ³	17.24%
52-week high ³	0.0430
52-week low ³	0.0100
50-day moving average ³	0.0186
200-day moving average ³	0.0202

Share statistics

Avg vol (3-month) ³	20.52k
Avg vol (10-day) ³	4.39k
Shares outstanding ⁵	59.09M
Implied shares outstanding ⁶	59.09M
Float ⁸	57.19M
% held by insiders ¹	8.63%
% held by institutions ¹	0.00%
Shares short ⁴	N/A
Short ratio ⁴	N/A
Short % of float ⁴	N/A
Short % of shares outstanding ⁴	N/A
Shares short (prior month ) ⁴	N/A

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	11 Nov 2020
Ex-dividend date ⁴	N/A
Last split factor ²	N/A
Last split date ³	N/A

Financial highlights

Currency in CAD.

Fiscal year

Fiscal year ends	29 Nov 2022
Most-recent quarter (mrq)	30 May 2023

Profitability

Profit margin	0.00%
Operating margin (ttm)	-235.98%

Management effectiveness

Return on assets (ttm)	-16.27%
Return on equity (ttm)	8.88%

Income statement

Revenue (ttm)	440k
Revenue per share (ttm)	0.01
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	189.68k
EBITDA	N/A
Net income avi to common (ttm)	299.62k
Diluted EPS (ttm)	0.0100
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	486.93k
Total cash per share (mrq)	0.01
Total debt (mrq)	N/A
Total debt/equity (mrq)	N/A
Current ratio (mrq)	6.17
Book value per share (mrq)	0.01

Cash flow statement

Operating cash flow (ttm)	-147.74k
Levered free cash flow (ttm)	-849.75k